June 5  2007 Senator Clinton Sponsors Bi Partisan Bills to Combat the Spread of Tuberculosis                                                                                                                                                                                                                                                                                                                                   Washington  DC  Senator Hillary Rodham Clinton today joined with Senators Sherrod Brown  D OH   Kay Bailey Hutchison  R TX   and Edward Kennedy  D MA  to introduce the Comprehensive TB Elimination Act of 2007 which is designed to fight the reemergence of tuberculosis  TB  in the U S  and help combat the disease globally  The legislation comes only days after the CDC announced that dozens of airline passengers were potentially exposed to extensively drug resistant tuberculosis  XDR TB  on international flights  From 1993 to 2006  there were 49 reported cases of XDR TB in the United  States  more than half of which occurred in New York State  Globally  almost 40 countries have reported cases of XDR TB to the World Health Organization  In 2006  more than 13 000 cases of active tuberculosis were reported in the U S   Senator Clinton is also a sponsor of the Stop Tuberculosis  TB  Now Act of 2007  sponsored by Senator Barbara Boxer which would require the President to provide assistance for tuberculosis  TB  prevention  treatment  and elimination at the international level    We cannot underestimate the seriousness of a disease like drug resistant TB and last weeks incident shows that we must pay closer attention to research into and treatment of this terrible disease  While there is no question that we need to address last weeks incident through better monitoring at our borders and increased communication between agencies  we must also ensure that we are doing everything we can to combat TB on a research and treatment basis  Our nations public health system and own health depends on it  Senator Clinton said    The bipartisan legislation introduced today would improve the ability of the Centers for Disease Control and Prevention  CDC  to respond to international outbreaks of extensively drug resistant tuberculosis  XDR TB   The legislation reauthorizes the CDCs TB program and increases its authorized funding level to  300 million for Fiscal Year 2008 for current CDC domestic activities related to TB  The legislation would expand CDC efforts to prevent  detect  and treat TB  with an emphasis on groups with disproportionately high infection rates including African Americans  Latinos and Asian Americans  The bill also clarifies the role of relevant branches of the Department of Health and Human Services  aimed at improving interagency collaboration for the elimination of TB  and reauthorizes the NIHs TB programs with a focus on improving NIHs capacity to research TB and develop the skills of researchers focused on TB  In addition the bill includes an extra  100 million in new funds for new tools to combat drug resistant TB including drugs  diagnostics  vaccines and public health interventions  The bill would expand TB research at CDC and the National Institutes of Health  NIH  into     New diagnostic and treatment tools    Testing the safety and efficacy of new drugs    Vaccines    At risk populations    The relationship between TB and HIV AIDS    Effective public health interventions  The Stop Tuberculosis  TB  Now Act of 2007  of which Senator Clinton is also a co sponsor  amends the Foreign Assistance Act of 1961 to give priority to activities described in the Stop TB Strategy  The bill also authorizes the President  through the United States Agency for International Development  USAID   to provide increased resources to the World Health Organization  WHO  and the Stop Tuberculosis Partnership to improve the capacity of countries with high TB rates and other affected countries to implement the Stop TB Strategy and specific strategies related to addressing drug resistant tuberculosis  XDR TB   The bill also authorizes appropriations for activities at the CDC which would lead to new diagnostic and treatment tools         